For the Quarter Ending December 2022
The North American Amlodipine Besylate market commenced in Q4 of 2022 on a declining note, with CFR New York prices settling at USD 51600/MT in October. The interrupting imports from China during the Golden week vacations in the first week of October resulted in low inventories among domestic retailers. Additionally, demand from the downstream pharmaceutical sector in the United States remained sluggish. However, these prices continued to drop in November and fell even further to USD 50460/MT in December in the US domestic market. The US supply chain gradually became better in H2 of 2022 as the country finally started to recover, and the port on the east coast significantly reduced ship backlogs. The US supply chains were adaptable because of the reduced shipping demand brought on by slower consumer spending and a decline in manufacturing activity in December. All these factors had a prominent effect on the downward price trend of Amlodipine Besylate in the US domestic market. York
The price trend for Amlodipine Besylate in the Asia Pacific region showed a downward trajectory in the Q4 of 2022. The Golden week closure of industrial facilities in China from October 1 and 7 resulted in a slow rate of contraction in the manufacturing sector this month. During the first half, merchants received orders from domestic and international buyers for urgent use only, and Amlodipine Besylate prices came to USD 33900/MT FOB Shanghai in October. However, after returning from the Golden week holiday, the industries resumed production, and the domestic manufacturers and suppliers met the total demand during the quarter with an acceptable supply of inventories on hand. Following the government’s decision to relax its zero-covid regulation in response to widespread protest and ubiquitous unrest in the country, which put the country once again in choppy waters, cases of Covid-19 started to appear in the key manufacturing hubs in China, which shocked the market yet again. Therefore, the chances of Amlodipine Besylate prices catching up to the modest increase in H2 of Q4 were decreased to USD 32870/MT in December.
German domestic market displayed weakening sentiments in the Q4 of 2022 as prices dropped from USD 54200/MT to USD 52870/MT from October to December. The primary factor for the ultimate decrease in price was the adequate availability of the product in the German market coupled with bearish demand from downstream pharmaceutical and healthcare industries. The price plunged was also initiated by dwindling offtakes from the domestic market, causing muted purchasing activity. Also, imports from Asia-Pacific countries had become normal as prices their drop due to Covid 19 issues. Moreover, the situation in Russia and the state of war in Ukraine all continued to have a detrimental effect on output. In the second half, only fewer traders were active in the market as they already had sufficient inventories and mainly waiting for a fresh supply. The pessimistic market sentiment provoked traders to get rid of their ample stock levels at a lower price.
For the Quarter Ending September 2022
In the North American region, the Amlodipine Besylate price trend observed an increasing trajectory in the third quarter of 2022 owing to enhanced demand from the downstream segment and limited supply among domestic traders. However, Amlodipine Besylate inventories were low in the domestic market due to lesser imports from the international market on account of lockdown restrictions and production on hold amidst maintenance work. Moreover, the buying activities were elevated due to rising offtakes from end-user pharmaceutical and healthcare sectors. Therefore, the CFR New York prices for Amlodipine Besylate in the United States displayed a 13.1% quarterly increment, with prices surging from USD 48200/MT to USD 52300/MT.
In the Asia Pacific, Amlodipine Besylate witnessed favorable market sentiments during the third quarter of 2022. However, FOB Shanghai prices increased from USD 34070/MT to USD 34770/MT from July to September 2022. The robust demand from several end-user pharmaceutical and healthcare industries has impacted the Amlodipine Besylate prices in the Chinese market. Various manufacturing factories underwent maintenance after the shutdown when the markets reopened in the closing week of July, which impacted the product supply in domestic and foreign suppliers throughout the H2 of the quarter. The market dynamics in China over the final weeks of Q3 were also badly influenced by extreme weather and economic issues.
In Europe, the Amlodipine Besylate prices resembled the similar market dynamics of North America and the Asia Pacific region. However, in Germany, the third quarter of 2022 saw an incline upto 12.1% in the price of Amlodipine Besylate, with CFR Hamburg values settled at USD 51200/MT in July and then rising even further to USD 56300/MT in September. The reason behind the price incline was hindered supplies and consistent demand from end-user industries. Also, water levels on the Rhine in Germany continue to fall in hot weather, resulting in higher shipping costs and disruption in trade activities, influencing the prices of Amlodipine Besylate to upsurge. Furthermore, rising import costs have forced domestic firms to alter their product lines to enhance profit margins.
For the Quarter Ending June 2022
The North American region dominates the Amlodipine Besylate API market with rising adoption of strategies by manufacturers in their unit. In the second quarter of 2022, Amlodipine Besylate API market sentiments in North America remained positive, with prices surging by 7.6% throughout the quarter. Due to the low production rate, there were insufficient inventories in the regional market to meet the firm demand pattern of Amlodipine Besylate in the regional market. Following the high cost of feedstock Amlodipine and Benzene sulfonate, Amlodipine Besylate prices increased in Q2 2022. In contrast, the prices stabilized in the second half of Q2 due to adequate supplies, and regular trading activities contributed to the stable prices in the month of June. The CFR prices for Amlodipine Besylate API were assessed at USD 46000/MT at the end of the quarter in the United States.
In the second quarter of 2022, the Asia Pacific market witnessed seesaw sentiments for Amlodipine Besylate API due to fluctuating demand from downstream pharmaceutical industries. The prices of Amlodipine Besylate API in the Indian market surged by 9.4% till May but started to scale down slightly in June. Supply chain disruption and port congestion issues due to the lockdown in China for two months affected the price trend of Amlodipine Besylate. However, demand from downstream pharmaceutical industries has been strong owing to limited inventories, encouraging the buyer's sentiment in the domestic market. By the end of the quarter, improvement in import frequencies from China led to adequate stock in the market, causing the value of Amlodipine Besylate to be slightly lower. Thus, by the end of June, Amlodipine Besylate API prices were assessed at USD 31145/MT in China.
During Q2 2022, the Europe Amlodipine Besylate API market also improved overall. In early Q2, Amlodipine Besylate prices rose in the European region. The uphill curve owed to the worsening economic crisis against the backdrop of the Russia-Ukrainian conflict. High prices of raw materials, and supply shortages, had a considerable effect on production rates and operational costs in the international market, affecting the price trend of Amlodipine Besylate. In addition, with the lockdown in China, importing activities were reduced, which lessened the availability of the Amlodipine Besylate API in the European market. As a result, enhanced demand from downstream pharmaceutical industries could not meet in the domestic market. The prices of Amlodipine Besylate API in Germany were settled at USD 50000/MT by the end of June.